Capital Investment And Policy Support Are Key To Biologics Development
This article was originally published in PharmAsia News
Executive Summary
At the recent 2010 China Bio-industry Convention, Tianjin SinoBiotech Chairman Yu Zailin noted recent progress and future challenges in the development of biologics